The application of innovative IT technologies in the field of oncological medicine represents one of the most advanced specialties to date, with a significant network of services in which the “precision” approach, or rather an approach that’s customized to the specific patient, ensures crucial differences in outcomes.
Furthermore, the field of oncology requires access to significant volumes of high quality data, as well as a large number of potential users.
In this context, artificial intelligence and machine learning offer valuable support in analyzing high volumes of data in a short period of time, testing concepts and implementations that are technically and scientifically sound and are also easy to adopt by both professionals and the patients themselves.
OncologIA is an industrial research and experimental development project, co-funded by Apulia Region through the European Regional Development Fund operational project Puglia ERDF 2014 - 2020, for the application of innovative IT technologies in the field of oncological medicine.
The project enables a highly precise modus operandi through the “sustainable” use of artificial intelligence and data, in compliance with the regulations that govern these applications and their ethical implications, these too binding.
Specifically, it is an advanced oncological diagnosis system based on AI/ML and Digital Twin (Digital Healthcare Identity) technologies delivered through a Cloud platform. It is designed to serve local oncology networks organized into HUB and Spoke models and to support medical personnel in identifying treatment options, potential complications, and the best follow-up strategy based on available local services.
In fact, OncologIA’s reference framework includes an ecosystem that leverages AI-driven technology at various levels: from predictive algorithms and algorithms which provide decision-support in clinical and logistical settings, to the establishment of Digital Healthcare Identities (IDS).
OncologIA is testing a “Digital Healthcare Identity” model of real patients, connected through specific sensors and devices. Through a simulation process, this model gives doctors and/or caregivers a near-real time “view” of the patient, creating a digital twin of the individual so as provide medical personnel with a comprehensive and integrated clinical overview of their patient’s health status, thus facilitating the identification of personalized, and therefore potentially more effective, therapies.
Cryptographic mechanisms and data validation
during the advanced collection and distribution phase (homomorphic IHE, PHE, and FHE encryption and strong anonymization)
High security Standards
also using differential privacy mechanisms for secure access to data (consent, revocation, and access logging, and with verification for IoT devices, wearables, etc., too)
Privacy compliance
through stringent adherence to national and international standards when it comes to the processing of personal data
Advanced Digital Twin
and a new management model for decentralized digital healthcare identities
Advanced “Health What If Analysis” system
for the analysis, visualization, and simulation of single and multiple models
Advanced analytics tools
based on artificial intelligence techniques for processing clinical data
Zero Knowledge Proof (ZKP) Techniques
to mathematically confirm the correctness of the association between the patient and the data that represents them within the system
Artificial Intelligence algorithms
to support the patient treatment and management model, through data-driven algorithms
Evolution of classic models of oncological treatment
through the dynamic management of assets corresponding to the identified macro-areas and interconnected to create a network of information in graph format, thus making it possible to analyze processes and rank the collected information
Use of frameworks related to the topic of ethical AI
to assess and manage (as required by European guidelines) the risks associated with the use of AI-based tools
during the advanced collection and distribution phase (homomorphic IHE, PHE, and FHE encryption and strong anonymization)
also using differential privacy mechanisms for secure access to data (consent, revocation, and access logging, and with verification for IoT devices, wearables, etc., too)
through stringent adherence to national and international standards when it comes to the processing of personal data
and a new management model for decentralized digital healthcare identities
for the analysis, visualization, and simulation of single and multiple models
based on artificial intelligence techniques for processing clinical data
to mathematically confirm the correctness of the association between the patient and the data that represents them within the system
to support the patient treatment and management model, through data-driven algorithms
through the dynamic management of assets corresponding to the identified macro-areas and interconnected to create a network of information in graph format, thus making it possible to analyze processes and rank the collected information
to assess and manage (as required by European guidelines) the risks associated with the use of AI-based tools
AI-driven systems, developed throughout time to enhance medical perceptive capability with more in-depth biological data, have today become true tools to support healthcare professionals. In fact, AI-driven technology provides real and constant support to all healthcare personnel, serving as a “second pair of eyes” in the smart cultural integration between humans and machines, based on the understanding that the human cognitive system is regardless always more “intelligent” than the artificial one.
Thanks to these new and advanced predictive tools and support systems for clinical decisions, doctors can delegate data calculations and operations to machines, allowing them to focus their time and energy on interpreting complex phenomena and exploring potential solutions.
Healthcare professionals can thus take advantage of the enormous potential of predictive AI systems in the prognostic field through the availability of Big Data and machine learning, while continuing to guide, supervise, and monitor patients using their own intelligence and typically human qualities like abstraction, intuition, flexibility and empathy to exercise a conservative and constructively critical approach.
The research is based on huge volumes of data analyzed in a short period of time
Big Data becomes information that supports the decision-making process
Traditional medicine becomes precision medicine
The research is based on huge volumes of data analyzed in a short period of time
Big Data becomes information that supports the decision-making process
Traditional medicine becomes precision medicine
Contact the Healthcare team
Copyright Almaviva S.p.A. 2018
Head office and offices
00137 Rome
Via di Casal Boccone, 188-190
tel. (+39)-06.39931
C.F./P.IVA 08450891000